The U.S. Food and Drug Administration has approved the SetPoint System, a neuroimmune modulation device for the treatment of adults living with moderate-to-severe rheumatoid arthritis (RA). The ...
MacRumors confirmed that the setting is on the iPhone 17 Pro, but did not confirm it is on the iPhone 17 or iPhone Air. For ...
Researchers at the Cavendish Laboratory, University of Cambridge have demonstrated a new way to control radiation in the terahertz range—an often-overlooked part of the electromagnetic spectrum—with ...
Camrelizumab Plus Famitinib versus Camrelizumab Alone and Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer: A Randomized, Phase II Study The interplay between the human ...
AZoOptics on MSN
Advances in Ultrafast Fiber Lasers and Mode-Locking Strategies
This review discusses how nonlinear optics and intelligent control techniques are advancing ultrafast laser technology, enhancing performance and reliability.
Credit: SetPoint Medical. The SetPoint System consists of a neurostimulation device that is surgically placed under general anesthesia on the vagus nerve. In a phase 3 study, the SetPoint neuroimmune ...
In a phase 3 study, the SetPoint neuroimmune modulation device was found to be an effective treatment for patients with difficult-to-treat RA. The Food and Drug Administration (FDA) has approved the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback